Rosacea Clinical Trial - A Clinical Endpoint Bioequivalence Study of

Clinical Trial Summary

A Randomized, Double-blind, Parallel-group, Three-arm, Placebo-controlled, Multi-Site Therapeutic Equivalence Study with Clinical End-points Comparing Test Product "Oxymetazoline hydrochloride Cream, 1%" to Reference Product "RHOFADE™ Cream, 1%" in the Treatment of Moderate to Severe Persistent Facial Erythema of Rosacea

See also
Status	Clinical Trial	Phase
Completed	`NCT05597462` - Impact of DFD-29 on Microbial Flora of Healthy, Adult Human Subjects When Administered Over 16 Weeks	Phase 1
Completed	`NCT02601963` - Safety and Efficacy Study of a Topical Minocycline Foam in Patients With Papulopustular Rosacea	Phase 2
Completed	`NCT02249065` - Mirvaso in Use Study	Phase 4
Completed	`NCT02292797` - Assessment of the Rosacea Prevalence in the General Population	N/A
Completed	`NCT01659853` - Efficacy and Safety Study Comparing CD07805/47 Gel 0.5% to Azelaic Acid Gel 15% in Subjects With Erythema of Rosacea	Phase 3
Completed	`NCT01426269` - Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo	Phase 4
Completed	`NCT00991198` - The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage	Phase 2
Terminated	`NCT04336163` - Skin Imaging to Inform Laser Treatments	N/A
Recruiting	`NCT04108897` - Analysis of the Microbiome in Rosacea	Early Phase 1
Completed	`NCT03872050` - Deep Phenotyping of Rosacea and Migraine
Active, not recruiting	`NCT06033352` - Potassium-titanyl Phosphate (KTP) Laser vs KTP Laser and Ivermectin Cream for Facial Rosacea	Phase 2
Completed	`NCT03263273` - Study to Evaluate the Safety and Efficacy of Topical Minocycline Gel in Patients With Papulopustular Rosacea	Phase 2
Completed	`NCT04508660` - CGB-400 for the Reduction of Facial Redness	Phase 1
Completed	`NCT04508205` - CGB-400 for the Reduction of Facial Redness and Bumps and Blemishes	Phase 1
Completed	`NCT05094700` - A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin Participants	N/A
Active, not recruiting	`NCT03211585` - EVALUATION OF THE EFFECT OF THE PERFECTA V-BEAM LASER ON ROSACEA	N/A
Completed	`NCT02576860` - Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle	Phase 3
Completed	`NCT02576847` - Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel	Phase 3
Completed	`NCT02637232` - Mirvaso® Utilisation and Patient Satisfaction Evaluation (MUSE)
Completed	`NCT02583009` - A Study to Evaluate the Safety and Efficacy of PAC-14028 Cream in Rosacea	Phase 2

NCT number	NCT03954444
Study type	Interventional
Source	Actavis Inc.
Contact
Status	Completed
Phase	Phase 3
Start date	April 15, 2019
Completion date	February 27, 2020

A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms